RenovoRx RNXT
NASDAQ RNXT
$1.56 -0.01 (-0.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

RenovoRx (RNXT) FCF Margin (2025 - 2026)

Updated

RenovoRx (RNXT) recorded FCF Margin of -323.21% in Q2 2026, up 222.29 percentage points from -545.50% a year earlier and up 335.58 percentage points from the prior quarter.

Analysis

RenovoRx (RNXT) FCF Margin (2025 - 2026) Analysis & Trends

On a TTM basis, RenovoRx's FCF Margin came in at -604.10% as of Jun 30, 2026; for FY2025, it came in at -977.29%, up 20271.54 percentage points from FY2024.

  • Across earlier years, FCF Margin came in at -21248.84% in FY2024.
  • Per Business Quant, the preceding three quarters came in at -658.79% (Q1 2026), -1268.91% (Q4 2025) and -853.38% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 13.97%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 15.81%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 20.19%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 32.79%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 13.22%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 16.07%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 23.50%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 33.60%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 12.70%
10 RenovoRx 70.84 Mn 70.84 Mn 766,000.00 -323.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -323.21%
Mar 31, 2026 -658.79%
Dec 31, 2025 -1,268.91%
Sep 30, 2025 -853.38%
Jun 30, 2025 -545.50%
Mar 31, 2025 -1,717.26%
API Access

RenovoRx FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=RNXT&period=max&api_key=YOUR_API_KEY